November 13th, 2026CHMP recommends EU approval of belzutifan plus lenvatinib for advanced ccRCCThe recommendation is backed by data from the phase 3 LITESPARK-011 trial.Read more
November 5th, 2026William Huang, MD, discusses the potential of histotripsy for renal tumorsWilliam Huang, MD, discusses histotripsy for renal tumors, the #HOPE4KIDNEY trial, and the technology’s potential to preserve kidney function.Read more